LYMPHOCYTE ACTIVATION INHIBITORS

摘要

Novel lymphocyte activation inhibitors which contain as the active ingredient antibodies binding specifically to a protein having an amino acid sequence represented by SEQ ID NO:1. Anti-HM1.24 antibody is preferable as the above antibody. The inhibitors are usable as remedies and preventives for autoimmune diseases, rejection reactions in organ transplantation or allergy.